NKF K/DOQI GUIDELINES 2000
GUIDELINES FOR PERITONEAL DIALYSIS ADEQUACY
XI. Biographical Sketches of the NKF-K/DOQI Peritoneal Dialysis Adequacy Work Group Members
The following are brief sketches that describe the professional training and experience, as well as principal business affiliations of the Work Group members. All Work Group members completed a disclosure statement certifying that any potential conflict of interest would not influence their judgment or actions concerning the NKF-K/DOQI.
Thomas A. Golper, MD, FACP (Work Group Chair), is Medical Director of the Medical Specialties Patient Care Center at Vanderbilt University Medical Center in Nashville, TN. He still practices nephrology and continues to serve as the Senior Medical Officer of Renal Disease Management, Inc, a disease management company headquartered in Youngstown, Ohio. Dr. Golper has been working to improve patient outcomes for the past 23 years. He serves as a CQI advisor to industry and has participated in guideline development for the management of peritonitis since 1986. Dr. Golper has published 136 articles and currently directs research on topics such as peritoneal fluid-drug interactions, peritonitis in PD, and atherosclerotic/thrombotic risk factors in ESRD. Active in many professional societies, he previously served on the Board of Directors for the Renal Physicians Association and currently serves on the Board of Directors and Executive Committee of the American Association of Kidney Patients. Dr. Golper also serves on the Advisory Board of K/DOQI and on several RPA Committees.
David Churchill, MDCM, FRCPC, FRCP (Edin) (Work Group Vice-Chair), is Professor of Medicine at McMaster University in Hamilton, Ontario, Canada. His funded clinical research activities have included urolithiasis research, polycystic kidney disease, quality of life in ESRD, economic analysis, erythropoietin in ESRD, and adequacy of peritoneal dialysis. He is co-principal investigator of the Canada-USA study (CANUSA) on the adequacy of peritoneal dialysis. He has over 100 peer-reviewed publications. Dr. Churchill has served on the scientific review panels for the NIH, Kidney Foundation of Canada, and the Ontario Ministry of Health, as well as on advisory committees for erythropoietin and dialysis services in Ontario. He has a cross-appointment in the Department of Clinical Epidemiology and Biostatistics, with a focus on evidence-based medicine.
Peter Blake, MB, FRCPC, FRCPI, is Director of Peritoneal Dialysis at the London Health Sciences Centre, London, Ontario, Canada and Associate Professor of Medicine at the University of Western Ontario. Dr. Blake is also Chair of the Canadian Society of Nephrology Workgroup of Peritoneal Dialysis and also Course Director of the US National Kidney Foundation course on Peritoneal Dialysis. His clinical research focuses on the areas of adequacy and nutrition in peritoneal dialysis and also in the management of chronic kidney failure in the predialysis phase. He has written or co-authored more than 50 publications in the area of dialysis. He is on the editorial board of the Journal of the American Society of Nephrology, Peritoneal Dialysis International, and Advances in Renal Replacement Therapy. He is also co-editor of the Third Edition of handbook of Dialysis.
John Burkart, MD, is Associate Professor of Internal Medicine/Nephrology and Director of Outpatient Dialysis Services (CAPD and HD) for the Section of Nephrology at Wake Forest University/Bowman Gray School of Medicine in Winston-Salem, North Carolina. Dr. Burkart has been an active clinical nephrologist for 11 years and manages a large nephrology and dialysis practice. He currently cares for 70 end-stage renal disease patients and participates in a group practice serving more than 250 dialysis patients. He serves as a consultant to industry and has actively participated in clinical trials and educational workshops. Dr. Burkart has written or co-authored more than 90 publications, and is currently involved in research related to adequacy of peritoneal dialysis, improving outcomes on peritoneal dialysis, and alternative osmotic agents for peritoneal fluid. He is a co-investigator in the Hemodialysis Study and serves on the editorial boards of Peritoneal Dialysis International and Advancement of Renal Replacement Therapy. Dr Burkart reported an affiliation with Baxter Healthcare.
Dinesh K. Chatoth, MBBS, is Assistant Professor of Medicine at the University of Arkansas for Medical Sciences and Medical Director of Dialysis Services for the John L. McClellan Veterans Affairs Medical Center in Little Rock, Arkansas. Dr. Chatoth received the JD Chastain Research Award in 1998 from the National Kidney Foundation of Arkansas. His main research interests are related to cardiovascular disease in peritoneal dialysis, pre-ESRD education and incremental dialysis, and sustained low efficiency dialysis in acute renal failure.
Catherine Firanek, RN, CNN, MBA, is Global Senior Clinical Marketing Manager for Baxter Healthcare Corporations Renal Division which develops, manufactures and markets hemodialysis and peritoneal dialysis products and services. She currently focuses on establishing clinical educational programs and marketing activities related to dialysis therapy development around the world. For the past 18 years, Ms. Firanek has been involved with peritoneal dialysis program establishment, patient care, research and educational development at Rush-Presbyterian St. Lukes Medical Center/Circle Medical Management in Chicago, IL. Both locally and nationally, Ms. Firanek has been actively involved with the National Kidney Foundation serving in several positions related to nursing educational development, board of directors and now as co-editor of the joint council quarterly publication and CNNT council member at a national level. She was a member of the DOQI PD Adequacy workgroup established in 1993. She has served in advisory and research roles related to industry and has published numerous articles in areas of peritoneal dialysis including urban population experience, peritonitis incidence and adequacy.
Denis Geary, MB, MRCP(UK), FRCPC, is Associate Professor, Department of Pediatrics, at the University of Toronto, and Chief of Nephrology at the Hospital for Sick Children in Toronto, Canada. Dr. Gearys clinical training took place in the United States, United Kingdom, and Ireland. He has practiced as a staff physician in pediatric nephrology for 15 years. Dr. Gearys publications involve the subjects of dialysis, and the growth and development of children with chronic kidney disease.
Frank Gotch, MD, is a consultant to the Renal Research Institute in New York and is Associate Professor of Medicine at UCSF. Dr. Gotch has worked in clinical dialysis and dialysis research , particularly quantification of therapy, for 30 years. He chaired the NIH Hemodialyzer evaluation Study Group which sets standards for dialyzer performance in 1972 and the National NIH conference on Adequacy of Hemodialysis in 1975. He served on the planning committee and as kinetic consultant to the National Cooperative Dialysis Study and serves on the Steering Committee of the current HEMO study and was Co-Principal Investigator of a Cooperative study of Randomized Peritoneal Dialysis Prescriptions and Clinical Outcome. He has over 100 publications and provides consultation in dialysis kinetics and dialysis systems development to industry. His current research interests are primarily concerned with modeling dialysis technology.
Alan S. Kliger, MD, FACP, is Clinical Professor of Medicine at Yale University School of Medicine and Director of the New Haven CAPD. He currently chairs the ESRD Network of New England, the Quality Improvement Committee of the Forum of ESRD Networks, and the Quality Patient Care Committee of the Renal Physicians Association. Dr. Kliger also serves on the National Kidney Foundations K/DOQI Support Group.
Stephen M. Korbet, MD, is Professor of Medicine at Rush Medical College and Associate Director of the Section of Nephrology at Rush-Presbyterian-St. Lukes Medical Center in Chicago Illinois. He also serves as Medical Director of Circle Medical Management Dialysis Facility. Dr. Korbet is currently a member of the International Society of Peritoneal Dialysis Committee on Education and Standards and Baxters International Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Active in research, Dr. Korbets interests include nephrotic syndrome, focal segmental glomerulosclerosis, and peritoneal dialysis. He has served on the editorial board of the American Journal of Kidney Disease, and currently serves on the editorial boards of the Journal of Nephrology, and Peritoneal Dialysis International.
Antonios Tzamaloukas, MD, FACP, is Chief of the Renal Section of the New Mexico VA Health Care Center and Professor of Medicine at the University of New Mexico School of Medicine. Dr. Tzamaloukas has been on the faculty of the University of New Mexico for 25 years. He has had a major interest in peritoneal dialysis for the past 15 years. He has more than 230 scientific publications and is a member of the editorial board of the International Journal of Artificial Organs, Peritoneal Dialysis International, Kidney International, and American Journal of Kidney Diseases. He is active in several professional societies. His main research interest is in adequacy and nutrition of dialysis patients.
Bradley Warady, MD, is Chief of Nephrology and Director of Dialysis and Transplantation at The Childrens Mercy Hospital, and Professor of Pediatrics at the University of Missouri Kansas City School of Medicine. Dr. Waradys clinical and research focus is end-stage renal disease, with particular emphasis on peritoneal dialysis. He established the Pediatric Peritoneal Dialysis Study Consortium and currently co-directs research projects on a number of topics including: growth hormone usage in pediatric dialysis patients; peritoneal dialysis adequacy in children; and intravenous iron therapy in pediatric patients receiving hemodialysis. He co-edited the book "CAPD/CCPD in Children" and has published more than 150 articles. Dr. Warady currently serves on the executive committees of the American Society of Pediatric Nephrology and the Nephrology section of the American Academy of Pediatrics. Dr. Warady also sits on the Editorial Board for the Advances of Renal Replacement Therapy.
© 2001 National Kidney Foundation, Inc